Telemus Capital’s Novo Nordisk NVO Stock Holding History

Telemus Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-8,710	Closed	-$234K	–	352
2016 Q2	$234K	Buy	+8,710	New	+$239K	0.03%	303

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Telemus Capital's NVO Position: Q3 2016 in Review

Telemus Capital sold out of Novo Nordisk (NVO) in Q3 2016, closing a stake of 8,710 shares — an estimated $234K sold.

Telemus Capital first reported a position in NVO in Q2 2016 and held it in 1 quarter. The position peaked at $234K in Q2 2016. 513 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

Telemus Capital reported no remaining Novo Nordisk position as of Q3 2016 after selling out during the quarter.
Telemus Capital sold 8,710 Novo Nordisk shares in Q3 2016, an estimated $234K.
Telemus Capital first reported a position in Novo Nordisk in Q2 2016 and held it in 1 quarter.
Telemus Capital's Novo Nordisk position peaked at $234K in Q2 2016.
513 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Telemus Capital's 13F filing for Q3 2016, filed 5 Oct 2016.